Evaluation of Computed Tomography, Clinical and Laboratory Findings of COVID-19 in Cancer Patients
Yükleniyor...
Dosyalar
Tarih
2020
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Aim: The aim of this study was to evaluate the computed tomography (CT), clinical andlaboratory findings of coronavirus disease 2019 (COVID-19) in cancer patients and to comparethe findings between polymerase chain reaction (PCR) positive and negative patients.Material and Methods: Twenty-three cancer patients with positive PCR tests and 22diagnosed as COVID-19 with clinical and radiological findings were included in the study. CTimages of the patients were evaluated simultaneously by two radiologists. Presence ofcomorbid diseases, symptoms and laboratory values were evaluated.Results: The most common CT involvement pattern was peripheral with 88.9% (n=40).Bilateral lung involvement rate was 57.8% (n=26). The most common finding was groundglass opacities (n=38, 84.5%). 35.6% (n=16) of these were accompanied by consolidation.Multifocal involvement was present in 62.2% (n=28) of the cases. The most frequentlyinvolved lobes were lower lobes. Other relatively common findings were septal thickening,subpleural streaking, and air bronchogram. The median neutrophil, lymphocyte, D-dimer,procalcitonin, C-reactive protein and lactate dehydrogenase values of the patients were 2000mm3, 1200 mm3, 1990 ng/mL, 30.7 mcg/L 15.8 mg/dl, 161 IU/L, respectively.Conclusion: Multifocal and bilateral involvement, and ground glass opacities were the mostcommon findings. However, higher rates of septal thickening, which is generally less common,suggest that the findings may be more severe in cancer patients. Most of the inflammatorymarkers were higher in PCR negative cases. Studies with more patients in multiple centers willprovide better comparison of the findings in cancer patients with the general population.
Açıklama
Anahtar Kelimeler
Kaynak
Düzce Tıp Fakültesi Dergisi
WoS Q Değeri
Scopus Q Değeri
Cilt
22
Sayı
S1
